ST. CLOUD HOSPITAL
- Type
- Teaching hospital
- Where
- SAINT CLOUD, MN
- Medicare CCN
- 240036
- Received
- $1,058,905 in 197 records, 2019 ($21,882 general, $1,037,023 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: St. Cloud Hospital Fuzzy (name and state)
- Business registration: St. Cloud Hospital DBA St. Benedict's Senior Community - Chateau Waters Fuzzy (name and state)
- Nonprofit contractor: St Cloud Hospital Fuzzy (name and state)
- Nonprofit: ST CLOUD HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 21 | $21,882 |
| 2019 | Research payment | 176 | $1,037,023 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Abbott Laboratories | 35 | $297,088 | 2019 |
| Cardiovascular Systems Inc. | 16 | $232,813 | 2019 |
| Boston Scientific Corporation | 31 | $154,518 | 2019 |
| Amgen Inc. | 6 | $104,570 | 2019 |
| Novartis Pharmaceuticals Corporation | 3 | $55,015 | 2019 |
| SANOFI US SERVICES INC. | 14 | $51,329 | 2019 |
| Medtronic Vascular, Inc. | 27 | $50,287 | 2019 |
| Inari Medical, Inc. | 12 | $24,009 | 2019 |
| Kowa Research Institute, Inc. | 6 | $18,315 | 2019 |
| AstraZeneca Pharmaceuticals LP | 2 | $14,612 | 2019 |
| PFIZER INC. | 17 | $13,600 | 2019 |
| Amarin Pharma, Inc. | 1 | $10,752 | 2019 |
| Medtronic, Inc. | 5 | $9,034 | 2019 |
| Incyte Corporation | 7 | $8,821 | 2019 |
| Merck Sharp & Dohme LLC | 2 | $5,400 | 2019 |
| Medline Industries LP | 1 | $2,957 | 2019 |
| Acerta Pharma LLC | 1 | $2,928 | 2019 |
| Pharmacyclics LLC, an AbbVie Company | 7 | $1,155 | 2019 |
| Siemens Medical Solutions USA, Inc. | 1 | $1,088 | 2019 |
| Spectrum Pharmaceuticals Inc. | 1 | $398 | 2019 |
| American National Red Cross | 1 | $193 | 2019 |
| Olympus America Inc. | 1 | $19 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 176 | $1,037,023 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 15 | $16,832 |
| Space rental or facility fees (teaching hospital only) | 3 | $3,750 |
| Charitable Contribution | 1 | $1,088 |
| Food and Beverage | 1 | $193 |
| Gift | 1 | $19 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $1,088 | Charitable Contribution | In-kind items and services | 2019 | ||
| 2019-12-31 | Abbott Laboratories | $105 | Research payment | In-kind items and services | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-12-27 | PFIZER INC. | $1,700 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-12-24 | Amgen Inc. | $2,467 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | VESALIUS-CV | 2019 |
| 2019-12-24 | Amgen Inc. | $1,150 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2019 |
| 2019-12-16 | Boston Scientific Corporation | $3,876 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2019 |
| 2019-12-16 | Boston Scientific Corporation | $560 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-12-13 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-12-11 | Medtronic, Inc. | $2,544 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-12-11 | SANOFI US SERVICES INC. | $2,302 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-12-10 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-12-06 | PFIZER INC. | $1,600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-11-25 | Medline Industries LP | $2,957 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Reprocessed Instruments Medical Supply, Reprocessing | 2019 | |
| 2019-11-21 | Kowa Research Institute, Inc. | $1,400 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-11-21 | Cardiovascular Systems Inc. | $1,105 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-11-18 | Boston Scientific Corporation | $82,846 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2019 |
| 2019-11-18 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-11-13 | Abbott Laboratories | $29,555 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-11-13 | SANOFI US SERVICES INC. | $3,994 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-11-13 | Medtronic Vascular, Inc. | $912 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2019 |
| 2019-11-13 | Abbott Laboratories | $422 | Research payment | Cash or cash equivalent | AMPLATZER PFO Occluder Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2019 |
| 2019-11-04 | Boston Scientific Corporation | $4,538 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | MANAGE HF | 2019 |
| 2019-11-04 | Boston Scientific Corporation | $3,398 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-11-04 | Boston Scientific Corporation | $1,750 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-11-01 | Abbott Laboratories | $6,025 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-10-30 | Cardiovascular Systems Inc. | $83,237 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-10-30 | Cardiovascular Systems Inc. | $2,000 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-10-30 | Abbott Laboratories | $1,102 | Research payment | Cash or cash equivalent | CardioMEMS Device, Cardiac Arrhythmias and Heart Failure | CardioMEMS HF System Post Approval Study | 2019 |
| 2019-10-28 | SANOFI US SERVICES INC. | $4,125 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-10-25 | Amgen Inc. | $17,432 | Research payment | In-kind items and services | Repatha Biological, Cardiology | VESALIUS-CV | 2019 |
| 2019-10-24 | Kowa Research Institute, Inc. | $7,305 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-10-23 | Abbott Laboratories | $12,489 | Research payment | Cash or cash equivalent | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-10-22 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-10-21 | Boston Scientific Corporation | $7,753 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2019 |
| 2019-10-21 | SANOFI US SERVICES INC. | $4,733 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-10-21 | Boston Scientific Corporation | $1,765 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | REPRISE IV | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $2,893 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $2,482 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $2,340 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $2,154 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $414 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $414 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-16 | Inari Medical, Inc. | $414 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-10-07 | Boston Scientific Corporation | $1,000 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-10-07 | Boston Scientific Corporation | $633 | Research payment | Cash or cash equivalent | EMBLEM Device, TACHY | UNTOUCHED | 2019 |
| 2019-10-07 | Boston Scientific Corporation | $285 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-10-02 | Cardiovascular Systems Inc. | $2,195 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-10-01 | Kowa Research Institute, Inc. | $434 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-09-30 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-09-30 | PFIZER INC. | $1,100 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-09-30 | Abbott Laboratories | $70 | Research payment | In-kind items and services | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-09-30 | Abbott Laboratories | $70 | Research payment | In-kind items and services | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-09-24 | Medtronic Vascular, Inc. | $10,254 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2019 |
| 2019-09-23 | SANOFI US SERVICES INC. | $927 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-09-19 | Medtronic, Inc. | $1,499 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-09-16 | Boston Scientific Corporation | $169 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-09-11 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-09-05 | Cardiovascular Systems Inc. | $1,950 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-09-04 | Abbott Laboratories | $1,250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure | 2019 | |
| 2019-09-04 | Abbott Laboratories | $1,250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure | 2019 | |
| 2019-09-03 | SANOFI US SERVICES INC. | $6,585 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-09-03 | Boston Scientific Corporation | $780 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-09-03 | Boston Scientific Corporation | $401 | Research payment | Cash or cash equivalent | EMBLEM Device, TACHY | UNTOUCHED | 2019 |
| 2019-08-26 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-08-22 | AstraZeneca Pharmaceuticals LP | $2,180 | Research payment | Cash or cash equivalent | IMFINZI Drug, Oncology | A Non-Interventional Primary Data Collection Study to Assess the Prevalence of PD-L1 High in First Line Metastatic and L | 2019 |
| 2019-08-22 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-08-19 | Boston Scientific Corporation | $9,716 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | MANAGE HF | 2019 |
| 2019-08-19 | Boston Scientific Corporation | $2,275 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-08-15 | Amgen Inc. | $2,195 | Research payment | In-kind items and services | Repatha Biological, Cardiology | VESALIUS-CV | 2019 |
| 2019-08-14 | Abbott Laboratories | $25,884 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-08-12 | SANOFI US SERVICES INC. | $2,480 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-08-08 | Cardiovascular Systems Inc. | $1,137 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-08-07 | Abbott Laboratories | $18,293 | Research payment | Cash or cash equivalent | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-07-30 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-07-25 | Cardiovascular Systems Inc. | $40,428 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-07-24 | Merck Sharp & Dohme LLC | $5,100 | Research payment | Cash or cash equivalent | MK-0859 Drug, CARDIOVASCULAR | HPS 3 , TIMI 55 REVEAL Randomized EValuation of the Effects of Anacetrapib through Lipid-modification A large-scale, ran | 2019 |
| 2019-07-24 | Abbott Laboratories | $1,102 | Research payment | Cash or cash equivalent | CardioMEMS Device, Cardiac Arrhythmias and Heart Failure | CardioMEMS HF System Post Approval Study | 2019 |
| 2019-07-24 | Abbott Laboratories | $845 | Research payment | Cash or cash equivalent | AMPLATZER PFO Occluder Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2019 |
| 2019-07-22 | SANOFI US SERVICES INC. | $12,109 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-07-18 | Kowa Research Institute, Inc. | $7,528 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-07-17 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-07-11 | Medtronic Vascular, Inc. | $3,426 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2019 |
| 2019-07-02 | Abbott Laboratories | $10,050 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-07-02 | SANOFI US SERVICES INC. | $4,109 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-07-02 | Cardiovascular Systems Inc. | $1,462 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-07-01 | Boston Scientific Corporation | $2,130 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-06-28 | Inari Medical, Inc. | $2,479 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-06-28 | Inari Medical, Inc. | $2,479 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-06-28 | Inari Medical, Inc. | $2,154 | Research payment | Cash or cash equivalent | FlowTriever Device, Venous Thrombectomy | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 2019 |
| 2019-06-24 | SANOFI US SERVICES INC. | $618 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-06-19 | PFIZER INC. | $1,000 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-06-19 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-06-19 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-06-14 | Boston Scientific Corporation | $2,790 | Research payment | Cash or cash equivalent | Acuity Device, Tachy | NAVIGATE X4 STUDY | 2019 |
| 2019-06-14 | Boston Scientific Corporation | $570 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-06-13 | Medtronic, Inc. | $1,629 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-06-12 | Medtronic Vascular, Inc. | $625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-06-06 | Cardiovascular Systems Inc. | $715 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-06-05 | Abbott Laboratories | $1,250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CardioMEMS HF System Device, Cardiac Arrhythmias and Heart Failure | 2019 | |
| 2019-06-04 | Medtronic Vascular, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-06-03 | Medtronic Vascular, Inc. | $846 | Research payment | Cash or cash equivalent | Attain Stability Quad | 2019 | |
| 2019-05-30 | Medtronic, Inc. | $750 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-05-20 | Boston Scientific Corporation | $3,851 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | MANAGE HF | 2019 |
| 2019-05-20 | Kowa Research Institute, Inc. | $1,600 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-05-20 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-05-20 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-05-20 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-05-16 | Medtronic Vascular, Inc. | $2,203 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2019 |
| 2019-05-15 | Abbott Laboratories | $21,132 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-05-08 | Incyte Corporation | $35 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-05-08 | Incyte Corporation | $12 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-05-06 | Boston Scientific Corporation | $855 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-05-06 | Boston Scientific Corporation | $401 | Research payment | Cash or cash equivalent | EMBLEM Device, TACHY | UNTOUCHED | 2019 |
| 2019-05-02 | Cardiovascular Systems Inc. | $1,235 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-05-02 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-05-02 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-05-01 | Abbott Laboratories | $2,151 | Research payment | Cash or cash equivalent | AMPLATZER PFO Occluder Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2019 |
| 2019-04-29 | Incyte Corporation | $200 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-04-24 | Abbott Laboratories | $23,649 | Research payment | Cash or cash equivalent | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-04-22 | SANOFI US SERVICES INC. | $618 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-04-18 | Cardiovascular Systems Inc. | $41,919 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-04-17 | Medtronic Vascular, Inc. | $1,250 | Research payment | Cash or cash equivalent | CareLink Device, Cardiac Diagnostics and Monitoring | BlueSync | 2019 |
| 2019-04-16 | PFIZER INC. | $1,000 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-04-16 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-04-16 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-04-16 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-04-16 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-04-16 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-04-16 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-04-10 | Abbott Laboratories | $4,920 | Research payment | Cash or cash equivalent | CardioMEMS Device, Cardiac Arrhythmias and Heart Failure | CardioMEMS HF System Post Approval Study | 2019 |
| 2019-04-10 | Medtronic, Inc. | $2,612 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-04-10 | American National Red Cross | $193 | Food and Beverage (2 payments) | In-kind items and services | 2019 | ||
| 2019-04-09 | Medtronic Vascular, Inc. | $5,000 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2019 |
| 2019-04-04 | Cardiovascular Systems Inc. | $1,137 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-04-03 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-04-02 | Medtronic Vascular, Inc. | $625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-04-01 | Abbott Laboratories | $3,500 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-04-01 | Abbott Laboratories | $2,300 | Research payment | Cash or cash equivalent | Xience V coronary stent system Device, Vascular | DAPT study | 2019 |
| 2019-04-01 | Boston Scientific Corporation | $1,034 | Research payment | Cash or cash equivalent | EMBLEM Device, TACHY | UNTOUCHED | 2019 |
| 2019-04-01 | Boston Scientific Corporation | $945 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-03-31 | Abbott Laboratories | $120 | Research payment | In-kind items and services | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-03-31 | Abbott Laboratories | $38 | Research payment | In-kind items and services | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-03-25 | SANOFI US SERVICES INC. | $706 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-03-23 | Olympus America Inc. | $19 | Gift | In-kind items and services | 2019 | ||
| 2019-03-22 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-03-21 | Abbott Laboratories | $3,000 | Research payment | Cash or cash equivalent | AMPLATZER PFO Occluder Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2019 |
| 2019-03-21 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | AMPLATZER PFO Occluder Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2019 |
| 2019-03-21 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-03-20 | Abbott Laboratories | $42,967 | Research payment | Cash or cash equivalent | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-03-18 | Boston Scientific Corporation | $5,775 | Research payment | Cash or cash equivalent | ACUITY Device, TACHY | NAVIGATE X4 STUDY | 2019 |
| 2019-03-18 | Boston Scientific Corporation | $3,623 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | MANAGE HF | 2019 |
| 2019-03-12 | Acerta Pharma LLC | $2,928 | Research payment | Cash or cash equivalent | CALQUENCE Drug, Oncology | A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP-196 in | 2019 |
| 2019-03-08 | Incyte Corporation | $26 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-03-08 | Incyte Corporation | $18 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-03-08 | Incyte Corporation | $6 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-03-07 | Cardiovascular Systems Inc. | $422 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-02-25 | Medtronic Vascular, Inc. | $1,600 | Research payment | Cash or cash equivalent | Attain Stability Quad | 2019 | |
| 2019-02-22 | Spectrum Pharmaceuticals Inc. | $398 | Research payment | Cash or cash equivalent | SPI-GCF-302 | 2019 | |
| 2019-02-21 | Amarin Pharma, Inc. | $10,752 | Research payment | Cash or cash equivalent | AMR101 Drug, Hypertriglyceridemia | A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the effect o | 2019 |
| 2019-02-20 | Medtronic Vascular, Inc. | $3,500 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2019 |
| 2019-02-20 | Medtronic Vascular, Inc. | $1,500 | Research payment | Cash or cash equivalent | CareLink Device, Cardiac Diagnostics and Monitoring | BlueSync | 2019 |
| 2019-02-20 | Merck Sharp & Dohme LLC | $300 | Research payment | Cash or cash equivalent | MK-0859 Drug, CARDIOVASCULAR | HPS 3 , TIMI 55 REVEAL Randomized EValuation of the Effects of Anacetrapib through Lipid-modification A large-scale, ran | 2019 |
| 2019-02-19 | Boston Scientific Corporation | $6,500 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-02-19 | Boston Scientific Corporation | $1,000 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | MANAGE HF | 2019 |
| 2019-02-19 | Boston Scientific Corporation | $120 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-02-18 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-02-13 | Abbott Laboratories | $20,992 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-02-07 | Cardiovascular Systems Inc. | $51,754 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-02-07 | Medtronic Vascular, Inc. | $146 | Research payment | Cash or cash equivalent | Onyx Device, Liquid Embolics | Onyx ONE Clear | 2019 |
| 2019-02-06 | Amgen Inc. | $68,275 | Research payment | In-kind items and services | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2019 |
| 2019-02-06 | Abbott Laboratories | $2,736 | Research payment | Cash or cash equivalent | AMPLATZER PFO Occluder Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER PFO Occluder Post Approval Study | 2019 |
| 2019-02-05 | Incyte Corporation | $8,523 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-02-05 | Medtronic Vascular, Inc. | $4,025 | Research payment | Cash or cash equivalent | Evera Device, Implantable Cardioverter Defibrillators (ICDs) | Tachy Prediction Download | 2019 |
| 2019-02-01 | Cardiovascular Systems Inc. | $812 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-01-31 | Medtronic Vascular, Inc. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-01-30 | Abbott Laboratories | $31,405 | Research payment | Cash or cash equivalent | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-01-30 | Novartis Pharmaceuticals Corporation | $1,209 | Research payment | Cash or cash equivalent | ILARIS Biological, IMMUNOLOGY | A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED EVENT DRIVEN TRIAL OF QUARTERLY SUBCUTANEOUS CANAKINUMAB IN THE PREVENTION | 2019 |
| 2019-01-30 | Abbott Laboratories | $190 | Research payment | Cash or cash equivalent | AMPLATZER Cardiac Plug Device, Cardiac Arrhythmias and Heart Failure | Amplatzer Cardiac Plug Trial | 2019 |
| 2019-01-28 | Novartis Pharmaceuticals Corporation | $50,099 | Research payment | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | PROSPECTIVE COMPARISON OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR ARNI VERSUS ACE INHIBITOR TRIAL TO DETERMINE IMPACT | 2019 |
| 2019-01-28 | SANOFI US SERVICES INC. | $5,862 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-01-28 | SANOFI US SERVICES INC. | $2,161 | Research payment | Cash or cash equivalent | SAR439954 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotaglif | 2019 |
| 2019-01-26 | Amgen Inc. | $13,050 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2019 |
| 2019-01-25 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-01-25 | PFIZER INC. | $600 | Research payment | Cash or cash equivalent | IBRANCE Drug, ONCOLOGY | PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI | 2019 |
| 2019-01-25 | Kowa Research Institute, Inc. | $46 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-01-22 | Boston Scientific Corporation | $1,750 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ENABLE MRI | 2019 |
| 2019-01-22 | Boston Scientific Corporation | $1,425 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-01-17 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-01-16 | Abbott Laboratories | $21,483 | Research payment | Cash or cash equivalent | AMPLATZER Amulet Left Atrial Appendage Occlude Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2019 |
| 2019-01-16 | Abbott Laboratories | $3,736 | Research payment | Cash or cash equivalent | CardioMEMS Device, Cardiac Arrhythmias and Heart Failure | CardioMEMS HF System Post Approval Study | 2019 |
| 2019-01-14 | Novartis Pharmaceuticals Corporation | $3,706 | Research payment | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | A MULTICENTER RANDOMIZED DOUBLE BLIND PARALLEL GROUP ACTIVE CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LCZ6 | 2019 |
| 2019-01-11 | Pharmacyclics LLC, an AbbVie Company | $165 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-01-08 | AstraZeneca Pharmaceuticals LP | $12,432 | Research payment | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Eval | 2019 |
| 2019-01-07 | Medtronic Vascular, Inc. | $1,750 | Research payment | Cash or cash equivalent | TYRX Device, Antibacterial Mesh | WRAP-IT | 2019 |
| 2019-01-03 | Cardiovascular Systems Inc. | $1,300 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In St. Cloud, MN, county Stearns County, MN, state Minnesota; placed by its city name.
| Measure | Place (city or town) St. Cloud, MN | County Stearns County, MN | State Minnesota |
|---|---|---|---|
| Population B01003 | 70,629 | 160,865 | 5,739,445 |
| Population, 2020 census P1 | 68,881 | 158,292 | 5,706,494 |
| Median age B01002 | 30.6 | 35.1 | 38.8 |
| Under 18 B01001 | 21.9% | 23.6% | 22.9% |
| 65 and over B01001 | 13.3% | 16.1% | 17.3% |
| Households B11001 | 27,807 | 61,403 | 2,307,955 |
| Foreign born B05002 | 13.5% | 7.9% | 8.7% |
| Median household income B19013 | $61,374 | $77,066 | $89,062 |
| Median family income B19113 | $80,689 | $99,842 | $113,993 |
| Per capita income B19301 | $32,108 | $38,286 | $48,237 |
| Poverty rate B17001 | 20.2% | 12.9% | 9.3% |
| Unemployment rate B23025 | 6.0% | 4.1% | 4.1% |
| Civilian labor force B23025 | 38,559 | 88,499 | 3,119,042 |
| Mean commute (minutes) B08013 | 19.8 | 21.7 | 22.7 |
| Bachelor's degree or higher B15003 | 30.4% | 28.8% | 39.4% |
| Housing units B25001 | 29,762 | 66,625 | 2,545,030 |
| Owner-occupied B25003 | 48.6% | 67.9% | 72.2% |
| Renters B25003 | 51.4% | 32.1% | 27.8% |
| Median home value B25077 | $225,000 | $273,400 | $329,300 |
| Median gross rent B25064 | $1,003 | $1,068 | $1,280 |
| White, not Hispanic B03002 | 64.5% | 80.2% | 75.9% |
| Black B03002 | 19.7% | 9.0% | 6.9% |
| Hispanic or Latino B03002 | 5.8% | 4.8% | 6.4% |
| Asian B03002 | 4.1% | 1.9% | 5.1% |
| American Indian and Alaska Native B03002 | 0.2% | 0.1% | 0.7% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in St. Cloud, MN.
Comments